Protective immunity to clinical malaria is modified by the genetic diversity of P. falciparum antigens
Authors:
- Myo T. NaungMNMyo T. Naung
- Ramin MazhariRMRamin Mazhari
- Rhea J. LongleyRLRhea J. Longley
- Somya MehraSMSomya Mehra
- Wilson WongWWWilson Wong
- Paolo BarengPBPaolo Bareng
- Moses LamanMLMoses Laman
- Benson KiniboroBKBenson Kiniboro
- Maria Ome-KaiusMOMaria Ome-Kaius
- Pascal MichonPMPascal Michon
- James BeesonJBJames Beeson
- Eizo TakashimaETEizo Takashima
Open Access
- 5 September 2026
- journal article
- Published by Elsevier in Journal of Infection
- Vol. 93 (4)
Abstract
No abstract availableFunding Information
- National Health and Medical Research Council (2018654)
- National Health and Medical Research Council (1161066)
- National Health and Medical Research Council (GNT2024622)
- National Health and Medical Research Council (GNT1173210)
This publication has 80 references indexed in Scilit:
- The RH5-CyRPA-Ripr Complex as a Malaria Vaccine TargetTrends in Parasitology, 2020
- Protective Immunity against Severe Malaria in Children Is Associated with a Limited Repertoire of Antibodies to Conserved PfEMP1 VariantsCell Host & Microbe, 2019
- Human Antibodies that Slow Erythrocyte Invasion Potentiate Malaria-Neutralizing AntibodiesCell, 2019
- Disordered epitopes as peptide vaccinesPeptide Science, 2018
- Human Antibodies Fix Complement to Inhibit Plasmodium falciparum Invasion of Erythrocytes and Are Associated with Protection against MalariaImmunity, 2015
- Intrinsic disorder within the erythrocyte binding-like proteins from Plasmodium falciparumBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2014
- A threshold concentration of anti-merozoite antibodies is required for protection from clinical episodes of malariaVaccine, 2013
- Malaria Vaccine Design: Immunological ConsiderationsImmunity, 2010
- Profiling humoral immune responses to P. falciparum infection with protein microarraysProteomics, 2008
- High levels of serum antibodies to merozoite surface protein 2 of Plasmodium falciparum are associated with reduced risk of clinical malaria in coastal KenyaVaccine, 2006